Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Chad A. Mirkin to Deliver Pittcon 2011 Plenary Lecture

Abstract:
Most Cited Chemist in the World (Thomson Reuters)

Chad A. Mirkin to Deliver Pittcon 2011 Plenary Lecture

Pittsburgh, PA | Posted on August 23rd, 2010

The Pittcon Program Committee is pleased to announce that Dr. Chad A. Mirkin, Professor of Chemistry, Northwestern University, Evanston, Illinois, will deliver the Pittcon 2011 Plenary Lecture, "Polyvalent DNA Architectures: New Modalities For Intracellular Gene Regulation and Detection" on Sunday, March 13, 2011, at 4:30 p.m., in the Sidney Marcus Auditorium, Georgia World Congress Center, Atlanta, Georgia.

Dr. Chad A. Mirkin is the Director of the International Institute for Nanotechnology, the George B. Rathmann Professor of Chemistry, Professor of Chemical and Biological Engineering, Professor of Biomedical Engineering, Professor of Materials Science & Engineering, and Professor of Medicine."

Dr. Mirkin summarizes, "Over the past decade, we have developed methods for modifying nanoparticles with oligonucleotides and explored how they can be used as designer constructs for preparing highly ordered, highly functional materials. Over the course of these studies, we have discovered many unusual fundamental properties that make these materials particularly useful in biodiagnostics and intracellular gene regulation."

This lecture will focus on the use of these modified nanoparticles in the highly selective and sensitive detection of nucleic acids and proteins. It will also introduce the concept of the "antisense" particle and other similarly functionalized particles. Such particles exhibit a range of unique properties that make them very well-suited for gene regulation. They can also be tailored to control the binding strength to complementary target sequences offering a means to control the degree of protein expression.

See complete abstract here: www.pittcon.org/technical/pdfs/2011/Mirkin_Abstract.pdf

Mirkin is a chemist and a world renowned nanoscience expert, who is known for his development of nanoparticle-based biodetection schemes, the invention of Dip-Pen Nanolithography, and contributions to supramolecular chemistry. He is the author of over 410 manuscripts and over 370 patents and applications, and the founder of three companies, Nanosphere, NanoInk, and AuraSense which are commercializing nanotechnology applications in the life science and semiconductor industries. At present, he is listed as the most cited chemist in the world (Thomson Reuters), and the top most cited nanomedicine researcher in the world (Nanomedicine Registry).

Dr. Mirkin has been recognized for his accomplishments with over 60 national and international awards.

The Plenary Lecture will be part of the Opening Session for Pittcon 2011 which will be held in Atlanta, Georgia, from March 13-18, 2011, Georgia World Congress Center. The Plenary Lecture is followed immediately by a complimentary mixer and poster session. Visit www.pittcon.org/ to get more information on Pittcon 2011.

####

For more information, please click here

Contacts:
Contact:

Melinda Stephens



Marian Nardozzi
800-825-3221

Copyright © Pittcon 2011

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Nanomedicine

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

Announcements

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Events/Classes

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014

Engineers develop new materials for hydrogen storage April 15th, 2014

Nanobiotechnology

Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014

In latest generation of tiny biosensors, size isn't everything: UCLA researchers overturn conventional wisdom on nanowire-based diagnostic devices April 11th, 2014

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE